<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_TAS_Taipei_Contribution skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:TAS Taipei/Contribution</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV class="return"><H1>X</H1></DIV><DIV class="yellow"><DIV class="box right"><DIV class="box2 right project" href="https://2017.igem.org/Team:TAS_Taipei/Background"><H6 class="navCap">Project</H6></DIV><DIV class="box2 right experiment" href="https://2017.igem.org/Team:TAS_Taipei/Experimental_Summary"><H6 class="navCap">Experiments</H6></DIV><DIV class="box2 right modeling" href="https://2017.igem.org/Team:TAS_Taipei/Model"><H6 class="navCap">Modeling</H6></DIV><DIV class="box2 right prototype" href="https://2017.igem.org/Team:TAS_Taipei/Applied_Design"><H6 class="navCap">Prototype</H6></DIV><DIV class="box2 right policy" href="https://2017.igem.org/Team:TAS_Taipei/Human_Practices"><H6 class="navCap">Human Practices</H6></DIV><DIV class="box2 right biosafety" href="https://2017.igem.org/Team:TAS_Taipei/Safety"><H6 class="navCap">Safety</H6></DIV><DIV class="box2 right about" href="https://2017.igem.org/Team:TAS_Taipei/Team"><H6 class="navCap">About Us</H6></DIV><DIV class="box2 right acknowledgments" href="https://2017.igem.org/Team:TAS_Taipei/Attributions"><H6 class="navCap">Attributions</H6></DIV></DIV><DIV class="blue"><DIV class="box3 left project" href="https://2017.igem.org/Team:TAS_Taipei/Background"><H1>Project</H1></DIV><DIV class="box3 left experiment" href="https://2017.igem.org/Team:TAS_Taipei/Experimental_Summary"><H1>Experiment</H1></DIV><DIV class="box3 left modeling" href="https://2017.igem.org/Team:TAS_Taipei/Model"><H1>Modeling</H1></DIV><DIV class="box3 left prototype" href="https://2017.igem.org/Team:TAS_Taipei/Applied_Design"><H1>Prototype</H1></DIV><DIV class="box3 left policy" href="https://2017.igem.org/Team:TAS_Taipei/Human_Practices"><H1>Human Practice</H1></DIV><DIV class="box3 left biosafety" href="https://2017.igem.org/Team:TAS_Taipei/Safety"><H1>Safety</H1></DIV><DIV class="box3 left about" href="https://2017.igem.org/Team:TAS_Taipei/Team"><H1>About Us</H1></DIV><DIV class="box3 left acknowledgments" href="https://2017.igem.org/Team:TAS_Taipei/Attributions"><H1>Attributions</H1></DIV></DIV></DIV><DIV class="cv" id="cv"><DIV class="row"><NAV class="pageNav col-lg-1" id="navbar"><UL class="nav"><LI><A href="#char" class="pageNavBig">CHARACTERIZE</A></LI><LI><A href="#SDS" class="pageNavSm">SDS-PAGE Gel</A></LI><LI><A href="#CR" class="pageNavSm">Congo Red Assay</A></LI></UL></NAV><DIV class="white col-lg-2">
                hi
            </DIV><DIV class="col-lg-10"><HEADER><DIV class="row"><H1 class="name col-lg-12">IMPROVE CHARACTERIZATION OF EXISTING PART </H1></DIV><DIV class="row"><H4 class="para col-lg-12"><B>We improved the characterization of <A href="http://parts.igem.org/Part:BBa_K342003">BBa_K342003</A> and <A href="http://parts.igem.org/Part:BBa_K805015">BBa_K805015</A>,</B> which contain the <I>ompR234</I> ORF and <I>csgD</I> ORF, respectively. We chose to characterize these parts because we wanted to use biofilm to capture nanoparticles. We looked through the distribution kit, found these two parts which regulate biofilm production, and tested them. We characterize the protein sizes of OmpR234 (BBa_K342003) and CsgD (BBa_K805015), and show that expression of OmpR234 and CsgD both increase biofilm production.
 
                        </H4></DIV></HEADER><SECTION class="main"><DIV class="row" id="char"><H1 class="col-lg-12 title2">CHARACTERIZATION OF BBa_K342003 &amp; BBa_K805015</H1></DIV><DIV class="row"><H4 class="para col-lg-12">
                            In order to characterize these existing parts, we cloned them behind a promoter, RBS, and in front of a transcriptional terminator (figures 3-8 and 3-9). PCR checks showed that cloning was successful (figure 3-11). Sequencing results from Tri-I Biotech confirmed that both of our constructs are correct. 
                        </H4></DIV><DIV class="row"><DIV class="image_container col-lg-6"><H4 class="subtitle"><B>Figure 3-8 CsgD expression with a strong promoter + strong RBS combination.</B><SPAN class="subCred"> Figure: Justin Y.</SPAN></H4></DIV><DIV class="image_container col-lg-6"><H4 class="subtitle"><B> Figure 3-9 OmpR234 expression with a strong promoter + strong RBS combination.</B><SPAN class="subCred"> Figure: Justin Y.</SPAN></H4></DIV></DIV><DIV class="row"><DIV class="image_container col-lg-8 col-lg-offset-2"><H4 class="subtitle"><B>Figure 3-11. PCR check for CsgD and OmpR full constructs. </B> The expected size of CsgD full construct is 1100 bp (orange box) and OmpR full construct is 1200 bp (blue box).<SPAN class="subCred"> Cloning: Catherine Y., Dylan L., Justin Y.</SPAN></H4></DIV></DIV><DIV class="row" id="SDS"><H1 class="col-lg-12 section-title">SDS-PAGE Gel</H1></DIV><DIV class="row"><DIV class="image_container col-lg-12"><H4 class="subtitle"><B>Figure 3-15 SDS-PAGE shows <I>E. coli</I> overexpressing CsgD or OmpR234.</B> Predicted sizes of the curli proteins are listed on the right, and <I>E. coli</I> expressing GFP was used as a positive control.<SPAN class="subCred"> Protein Gel &amp; Figure: Justin Y.</SPAN></H4></DIV></DIV><DIV class="row"><H4 class="para col-lg-12">
                            SDS-PAGE was performed using transformed and lysed <I>E. coli</I> cultures. <B>Bacteria overexpressing CsgD and OmpR234 showed darker bands at 25 kDa and 27 kDa, respectively,</B> compared to controls that only contain the respective ORFs.
                        </H4></DIV><DIV class="row" id="CR"><H1 class="col-lg-12 section-title">Congo Red Assay</H1></DIV><DIV class="row"><H4 class="para col-lg-12">
                            To test if the overexpression of CsgD or OmpR234 actually lead to faster and greater biofilm production, we used Congo Red (CR), a dye commonly used to measure biofilm production (Reinke &amp; Gestwicki 2011). CR solution mixed with bacterial liquid cultures were grown in 12-well plates with glass coverslips, and incubated at 37ËšC for one day. The samples were then washed with PBS and dried. Any stained biofilm on the glass coverslips was solubilized in ethanol, and absorbance was measured at 500 nm (figures 3-16 and 3-17). If biofilms were present, the solution would appear red, which could be quantified by an absorbance value. 
                        </H4></DIV><DIV class="row"><H4 class="para col-lg-12">
                            We find that <B>overexpressing either CsgD or OmpR234 increases biofilm production,</B> as we hypothesized (figure 3-16 and 3-17). In our experiments, overexpression of CsgD leads to about twice the amount of biofilm compared to BBa_K850015 (figure 3-16), whereas overexpression of OmpR234 leads to about 8 times more biofilm compared to BBa_K342003 (figure 3-17). When bacteria expressing OmpR234 was grown in petri dishes, biofilms also appeared thicker compared to controls (figure 3-18).
                        </H4></DIV><DIV class="row"><DIV class="image_container col-lg-6"><H4 class="subtitle"><B> Figure 3-16: Overexpression of CsgD (BBa_K2229100) doubles biofilm production </B> A) Congo red assay stains biofilm (red). B) Stained biofilm is solubilized in ethanol. C) Absorbance is measured at 500 nm.<SPAN class="subCred"> Experiment &amp; Figure: Yvonne W.</SPAN></H4></DIV><DIV class="image_container col-lg-6"><H4 class="subtitle"><B> Figure 3-17 Overexpression of OmpR234 (BBa_K2229200) leads to ~8 times more biofilm production than control (BBa. </B> A) Congo red assay stains biofilm (red). B) Stained biofilm is solubilized in ethanol. C) Absorbance is measured at 500 nm.<SPAN class="subCred"> Experiment &amp; Figure: Yvonne W.</SPAN></H4></DIV></DIV><DIV class="row"><DIV class="image_container col-lg-8 col-lg-offset-2"><H4 class="subtitle"><B> Figure 3-18 Overexpression of OmpR234 (BBa_K2229200) produces more biofilm compared to BBa_K342003, which contains just the ORF.</B><SPAN class="subCred"> Experiment &amp; Figure: Yvonne W.</SPAN></H4></DIV></DIV></SECTION></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>